JPWO2021007659A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021007659A5
JPWO2021007659A5 JP2022500796A JP2022500796A JPWO2021007659A5 JP WO2021007659 A5 JPWO2021007659 A5 JP WO2021007659A5 JP 2022500796 A JP2022500796 A JP 2022500796A JP 2022500796 A JP2022500796 A JP 2022500796A JP WO2021007659 A5 JPWO2021007659 A5 JP WO2021007659A5
Authority
JP
Japan
Prior art keywords
alkyl
benzo
pentyl
chromen
trimethyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022500796A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022540433A (ja
JP2022540433A5 (https=
Publication date
Application filed filed Critical
Priority claimed from PCT/CA2020/050965 external-priority patent/WO2021007659A1/en
Publication of JP2022540433A publication Critical patent/JP2022540433A/ja
Publication of JP2022540433A5 publication Critical patent/JP2022540433A5/ja
Publication of JPWO2021007659A5 publication Critical patent/JPWO2021007659A5/ja
Ceased legal-status Critical Current

Links

JP2022500796A 2019-07-12 2020-07-10 カンナビノイド誘導体 Ceased JP2022540433A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962873697P 2019-07-12 2019-07-12
US62/873,697 2019-07-12
PCT/CA2020/050965 WO2021007659A1 (en) 2019-07-12 2020-07-10 Cannabinoid derivatives

Publications (3)

Publication Number Publication Date
JP2022540433A JP2022540433A (ja) 2022-09-15
JP2022540433A5 JP2022540433A5 (https=) 2025-02-14
JPWO2021007659A5 true JPWO2021007659A5 (https=) 2025-02-14

Family

ID=74209629

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022500796A Ceased JP2022540433A (ja) 2019-07-12 2020-07-10 カンナビノイド誘導体

Country Status (4)

Country Link
US (1) US20220242856A1 (https=)
EP (1) EP3997084A4 (https=)
JP (1) JP2022540433A (https=)
WO (1) WO2021007659A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3997098A4 (en) 2019-07-12 2023-10-11 Canopy Growth Corporation CANNABINOIDS DERIVATIVES
WO2021007663A1 (en) 2019-07-12 2021-01-21 Canopy Growth Corporation Cannabinoid derivatives
JP2022540586A (ja) 2019-07-12 2022-09-16 キャノピー グロウス コーポレイション カンナビノイド誘導体
WO2021062559A1 (en) 2019-10-02 2021-04-08 Canopy Growth Corporation Cannabinoid derivatives
EP4038058A4 (en) * 2019-10-02 2023-10-25 Canopy Growth Corporation Cannabinoid derivatives
EP4065554A4 (en) 2019-11-26 2024-01-10 Canopy Growth Corporation CANNABIGEROL DERIVATIVES AND THEIR USE AS CANNABINOID RECEPTOR MODULATORS
KR20240096817A (ko) 2020-05-19 2024-06-26 사이빈 아이알엘 리미티드 중수소화된 트립타민 유도체 및 사용 방법
US20240317701A1 (en) 2020-12-17 2024-09-26 Nalu Bio, Inc. Synthesis of cannabidiol and analogs thereof, and related compounds, formulations, and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3325490A (en) * 1965-02-23 1967-06-13 Rexall Drug Chemical Substituted 1-hydroxydibenzopyrans
US20080064679A1 (en) * 2004-06-24 2008-03-13 Martin Billy R Water Soluble Cannabinoids
EP2020850A4 (en) * 2006-05-01 2010-10-13 Eastern Virginia Med School NEW CANNABINOIDS AND METHOD FOR THEIR USE
WO2019234728A1 (en) * 2018-06-04 2019-12-12 Al&Am Pharmachem Ltd. Cannabinolic acid derivatives and uses thereof

Similar Documents

Publication Publication Date Title
JP6110859B2 (ja) ヤヌスキナーゼ阻害剤としてのピラゾールカルボキサミド
JP5583694B2 (ja) Cb2受容体を調節するピロリジン化合物
JP5749162B2 (ja) Cb2受容体を調節するスルホン化合物
TWI808305B (zh) 作為法尼醇x受體調節劑之經取代雙環化合物
BRPI0707427A2 (pt) composto ou um sal farmaceuticamente aceitável do mesmo, método para tratar dislipidemia, aterosclerose, e diabetes e complicações da mesma, para elevar os nìveis plásmicos de hdl, e para diminuir triglicerìdeos plásmicos, composição farmacêutica, e, uso de um composto ou de um sal farmaceuticamente aceitável do mesmo
JP2004517848A (ja) 抗ウイルス剤
CA2747419A1 (en) Sulfonamide derivatives
AU2007292993A1 (en) Pyridin-4-yl derivatives as immunomodulating agents
JP2011520884A (ja) Cb2受容体を変調するスルホン化合物
AU2009220861B2 (en) Pyridin-2-YL derivatives as immunomodulating agents
NZ601967A (en) Pde10 inhibitors and related compositions and methods
CN114008025A (zh) Acss2抑制剂和其使用方法
JP2012515787A (ja) 自己免疫疾患および炎症性疾患の処置におけるs1pアゴニストとしての置換オキサジアゾール誘導体
US8399451B2 (en) Heterocyclic compounds
JPWO2021007659A5 (https=)
WO2010005572A2 (en) Alpha-keto heterocycles as faah inhibitors
JP2017523223A5 (https=)
JP2016514711A (ja) ヤヌスキナーゼ阻害剤としての非環式シアノエチルピラゾロピリドン
KR20100122489A (ko) 아제티딘-유도 화합물, 그의 제조 방법 및 그의 치료학적 용도
JP5735634B2 (ja) スフィンゴシン−1−リン酸受容体1アゴニストとしての4−(5−イソオキサゾリルまたは5−ピラゾリル−1,2,4−オキサジアゾール−3−イル)−マンデル酸アミド化合物
JP7038460B2 (ja) 二環性含窒素複素環誘導体およびそれらを含有する医薬組成物
JPWO2021102569A5 (https=)
JPWO2021007661A5 (https=)
JP3856829B2 (ja) オキサゾリジノン誘導体、その製造及び治療的使用
JPWO2021062557A5 (https=)